We are live on ! Find out more
NAM

Needelman Asset Management Portfolio holdings

AUM $46M
1-Year Est. Return 8.27%
This Fund
S&P 500
This Quarter Est. Return
+0.97%
1 Year Est. Return
+8.27%
3 Year Est. Return
+30.52%
5 Year Est. Return
+74.86%
10 Year Est. Return
AUM
$31.2M
AUM Growth
-$453K
Cap. Flow
-$586K
Cap. Flow %
-1.88%
Top 10 Hldgs %
38%
Holding
38
New
Increased
Reduced
23
Closed
1

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
MRSH
Marsh
MRSH
+$210K
2
AAPL icon
Apple
AAPL
+$115K
3
INTC icon
Intel
INTC
+$41K
4
IBM icon
IBM
IBM
+$28.6K
5
JNJ icon
Johnson & Johnson
JNJ
+$27.5K

Sector Composition

Rank Sector Weight
1 Healthcare 25.92%
2 Financials 22.79%
3 Technology 12.59%
4 Industrials 11.33%
5 Consumer Staples 10.21%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AAPL icon
1
Apple
AAPL
$4.72T
$1.34M 4.29%
53,084
-4,680
-8% -$115K
BAC icon
2
Bank of America
BAC
$430B
$1.29M 4.14%
75,751
-245
-0.3% -$3.9K
JNJ icon
3
Johnson & Johnson
JNJ
$624B
$1.23M 3.93%
11,495
-265
-2% -$27.5K
INTC icon
4
Intel
INTC
$504B
$1.21M 3.88%
34,757
-1,210
-3% -$41K
MKL icon
5
Markel Group
MKL
$24.5B
$1.19M 3.82%
1,870
HON icon
6
Honeywell
HON
$78B
$1.16M 3.71%
13,839
-245
-2% -$20.8K
ELV icon
7
Elevance Health
ELV
$82.3B
$1.15M 3.69%
9,615
-190
-2% -$21.8K
UNH icon
8
UnitedHealth
UNH
$385B
$1.13M 3.62%
13,095
-65
-0.5% -$5.49K
JPM icon
9
JPMorgan Chase
JPM
$930B
$1.08M 3.47%
17,943
-250
-1% -$14.6K
BRK.B icon
10
Berkshire Hathaway Class B
BRK.B
$1.06T
$1.08M 3.46%
7,805
TEVA icon
11
Teva Pharmaceuticals
TEVA
$36.3B
$993K 3.18%
18,475
-185
-1% -$9.8K
PG icon
12
Procter & Gamble
PG
$342B
$981K 3.15%
11,716
-70
-0.6% -$5.74K
PFE icon
13
Pfizer
PFE
$143B
$958K 3.07%
34,143
QCOM icon
14
Qualcomm
QCOM
$180B
$943K 3.02%
12,615
-95
-0.7% -$7.27K
AON icon
15
Aon
AON
$76B
$929K 2.98%
10,600
YUM icon
16
Yum! Brands
YUM
$40.6B
$883K 2.83%
17,068
CB
17
DELISTED
CHUBB CORPORATION
CB
$842K 2.7%
9,250
-20
-0.2% -$1.82K
EMR icon
18
Emerson Electric
EMR
$81.2B
$839K 2.69%
13,405
-75
-0.6% -$4.87K
KMB icon
19
Kimberly-Clark
KMB
$35.6B
$826K 2.65%
8,008
MRK icon
20
Merck
MRK
$322B
$822K 2.64%
14,525
-157
-1% -$8.82K
DEO icon
21
Diageo
DEO
$45.7B
$807K 2.59%
6,989
-50
-0.7% -$6.05K
FLR icon
22
Fluor
FLR
$7.44B
$795K 2.55%
11,900
-145
-1% -$10.7K
CVX icon
23
Chevron
CVX
$387B
$776K 2.49%
6,505
BMY icon
24
Bristol-Myers Squibb
BMY
$126B
$750K 2.4%
14,655
GE icon
25
GE Aerospace
GE
$362B
$740K 2.37%
6,028

Similar funds

Needelman Asset Management's Q3 2014 Portfolio in Review

As of Q3 2014, Needelman Asset Management held 38 positions worth $31.2M, down 1.4% from $31.6M the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Trading was light in Q3 2014: portfolio turnover was 2.6%. Needelman Asset Management opened no new positions and exited 1, leaving the 38-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 26% of assets, up from 25% a quarter earlier, followed by Financials and Technology.

  • Needelman Asset Management's biggest Q3 2014 reduction was Apple, cutting an estimated $115K.
  • Needelman Asset Management fully exited Marsh in Q3 2014, selling an estimated $210K.
  • Needelman Asset Management's ten largest holdings make up 38% of its $31.2M portfolio in Q3 2014.
  • Needelman Asset Management opened 0 new positions and closed 1 in Q3 2014.
  • Needelman Asset Management's portfolio value fell 1.4% quarter-over-quarter to $31.2M.

Based on Needelman Asset Management's 13F filing for Q3 2014, filed 3 Oct 2014.